Our friends at TIFA are hosting a webinar on advancing pediatric TB diagnosis with stool-based testing on Oct 31 at 8am EST! Register here: https://t.co/pPuJznP3FF
Check out TB DIAH's new MEL Plan Template and Guidance! This is a MUST-HAVE for measuring a project's progress toward achieving programmatic results and generating learning to inform the adaptation of activities based on evidence. Click here for access: https://t.co/DUow8KlZPG
TB DIAH began supporting the DRC's ongoing efforts to strengthen its national #TB program in 2021. Read more about the background, process and key learnings from three years of engagement here: https://t.co/N12HrZfD99
TB DIAH hosted a meeting on Wednesday in Bishkek to discuss the project’s key achievements in the Kyrgyz Republic. Over the past three years, the project contributed to strengthening the #TB M&E policy environment and advancing the use of data to inform decision making.
TB DIAH's #TB Contact Investigation (TBCI) for Program Managers e-course covers TBCI programming, technical approaches, and monitoring and evaluation for managers. Check out the course here: https://t.co/erWrn6IYSa
Starting in 1 hour! USAID, Partners In Health, and Harvard Medical School's Center for Global Health Delivery are continuing the discussion on incorporating TB burden estimates into case finding efforts! Register for the final session: https://t.co/KoaJVJYOcz
Starting in 1 hour! USAID, Partners In Health, and Harvard Medical School's Center for Global Health Delivery are discussing incorporating TB burden estimates into case finding efforts! Register for TODAY's session: https://t.co/08HdCoZgQn and/or TOMORROW: https://t.co/KoaJVJYOcz
TOMORROW: Join USAID, Partners In Health, and Harvard Medical School's Center for Global Health Delivery for a discussion on incorporating TB burden estimates into case finding efforts! Register for Tuesday https://t.co/08HdCoZgQn and/or Wednesday https://t.co/KoaJVJYOcz
The Data-to-Action Continuum Toolkit is a maturity model based tool that assesses national #TB programs data use capabilities. Participants can use assessment data processed in real-time to develop priority actions based on country needs. Learn more here: https://t.co/dIqN2a3J6m
WHO has launched a new course series on #TB community-based services! These courses include awareness raising, risk communication, mobilization and meaningful engagement of community. Find them here: https://t.co/skfaTdYDk9
USAID, Partners In Health, and Harvard Medical School's Center for Global Health Delivery are hosting a 2-day virtual meeting on incorporating TB burden estimates into case finding efforts! Register for Day 1: https://t.co/08HdCoZgQn and/or Day 2: https://t.co/KoaJVJYOcz
TB Situation Rooms can improve #TB programming by supporting the review, analysis, and interpretation of TB data in as near to real-time as possible! Check our new TBSR Management and Implementation Guide and learn how to set up a TBSR in your context: https://t.co/rkluXRpuwd
TB DIAH recently introduced the #TB Situation Room (SR) Implementation and Management Guide, a new how-to resource! Missed the webinar? Watch the recording here: https://t.co/68NCPUk7D6
Interested in learning more about HIV-Associated #TB? This review article in the New England Journal of Medicine details recent advances in relevant research, focusing on countries with a particularly high disease burden.
https://t.co/AuKdwbdVzS
Join USAID, Partners in Health, and Harvard Medical School-Center for Global Health Delivery for a 2-day virtual meeting (Sept 10 & 11) discussing ways the global TB community can incorporate TB burden estimates into active case finding efforts. Registration details to follow!
The fight to #EndTB is one of the most important public health initiatives. In this NY Times opinion piece, Dr. Atul Gawande details the progress that can be made in to end #TB if action is taken quickly.
https://t.co/F6o0QMQ5iW
Military #TB, a fatal type of tuberculosis, has delayed diagnosis and high mortality rates due to its relatively low caseload. Wei et al. examined its clinical characteristics and prognostic factors in this recent journal article:
https://t.co/ctP7eD8kbO
Would a pan-tuberculosis treatment regimen be a cost-effective way to #EndTB? Ryckman et al. examine this question in this recent Lancet article modeling pan #TB treatment in three different contexts:
https://t.co/YKIHEmFOqY